Vivotif-Kapseln
Replacement
|
Medicines
|
10/02/2011
The marketing authorization holder has informed its supplied customers that results from stability data indicate a possible shortfall of the required active ingredient content by the end of the shelf life. The affected batch currently meets all quality and efficacy requirements, and the recall is being implemented solely as a precautionary measure and will be replaced with new, unaffected product.
| Name of the medicinal product | Vivotif - Kapseln |
|---|---|
| Marketing authorisation number(s) | 2-00011 |
| Marketing authorisation holder | Crucell Italy Srl Vertrieb: Baxter Healthcare GmbH |
| Batch number(s) | 3001835 |
| Expiry date | 09/04/2019 |
| Classification of the recall | 3 |
| BASG reference number | INS-640.001-0003 |
Further inquiry note
Page last modified:
12/07/2022